Try our beta test site
8 studies found for:    sapacitabine
Show Display Options
Rank Status Study
1 Unknown  Study of Sapacitabine in Acute Myeloid Leukemia (AML)
Condition: Acute Myeloid Leukemia
Intervention: Drug: sapacitabine and decitabine
2 Recruiting A Study of Oral Sapacitabine and Oral Seliciclib in Patients With Advanced Solid Tumors
Condition: Advanced Solid Tumors
Intervention: Drug: sapacitabine and seliciclib
3 Terminated A Study of Oral Sapacitabine in Patients With Previously Treated Non-Small Cell Lung Cancer
Condition: Non-small Cell Lung Cancer
Intervention: Drug: sapacitabine
4 Active, not recruiting Sapacitabine, Cyclophosphamide, Rituximab for Relapsed Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma (CLL/SLL) With Deletion (11q22-23)
Condition: Leukemia
Interventions: Drug: Cyclophosphamide;   Drug: Rituximab;   Drug: Sapacitabine
5 Unknown  A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia
Condition: Acute Myeloid Leukemia
Interventions: Drug: Sapacitabine and decitabine;   Drug: Decitabine
6 Completed Safety and Pharmacology Study of Sapacitabine to Treat Advanced Leukemias or Myelodysplastic Syndromes
Conditions: Leukemias;   Myelodysplastic Syndromes
Intervention: Drug: sapacitabine
7 Unknown  Efficacy Study of Oral Sapacitabine to Treat Acute Myeloid Leukemia in Elderly Patients
Condition: Acute Myeloid Leukemia
Interventions: Drug: sapacitabine;   Drug: Sapacitabine
8 Terminated A Randomized Phase II Study of Oral Sapacitabine in Patients With Advanced Cutaneous T-cell Lymphoma
Condition: Cutaneous T-cell Lymphoma (CTCL)
Intervention: Drug: Sapacitabine

Study has passed its completion date and status has not been verified in more than two years.